Navigation Links
Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
Date:8/19/2009

ation can be found at www.mpsvi.com.

About Naglazyme

Naglazyme(R) is the first and only enzyme replacement therapy indicated for the treatment of MPS VI. Naglazyme is indicated for patients with MPS VI. Naglazyme has been shown to improve walking and stair-climbing capacity.

The most common adverse events observed in clinical trials in Naglazyme-treated patients were headache, fever, arthralgia, vomiting, upper respiratory infections, abdominal pain, diarrhea, ear pain, cough, and otitis media. Severe reactions included angioneurotic edema, hypotension, dyspnea, bronchospasm, respiratory distress, apnea, and urticaria. The most common symptoms of infusion reactions included fever, chills/rigors, headache, rash, and mild to moderate urticaria. Nausea, vomiting, elevated blood pressure, retrosternal pain, abdominal pain, malaise, and joint pain were also reported. No patients discontinued for adverse events and all patients who completed the double-blind portion of the trial continued to receive weekly infusions of Naglazyme. Nearly all patients developed antibodies as a result of treatment, but the level of the immune response did not correlate with the severity of adverse events. Because antihistamine use may increase the risk of apneic episodes, evaluation of airway patency should be considered prior to the initiation of treatment. Consideration to delay Naglazyme infusion should be given when treating patients who present with an acute febrile or respiratory illness. Additional information can be found at www.naglazyme.com.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (M
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan
2. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
3. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
4. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
5. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
6. CRF announces late breaking trials to be presented at TCT 2009 in San Francisco
7. Webinar on "Physician Engagement - Diagnosing Generational Differences" Presented by Morehead Associates
8. Webinar on "Physician Engagement - Diagnosing Generational Differences" Presented by Morehead Associates
9. President Obama Presented With Startling Book The Art of Conscious Parenting by the American Foundation for Conscious Parenting
10. 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
11. Shoulder Surgery Doesn't Prevent Return to Sports, According to New Study presented at AOSSM Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Angeles (PRWEB) May 19, 2013 Yeast infections ... can appear in sensitive areas of the human body. A ... Yeastrol. This new formula provides a unique method of application ... new spray solution is now provided to men and women ... is naturally absorbed in the body through food and is ...
(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...
(Date:5/19/2013)... 19, 2013 Beginning Wednesday, May 29 and ... Center (RRVBC) will feature “Hot Dog Wednesdays" and Ice Cold ... will provide hot dogs and all the fixin's to donors ... day throughout the summer. “Donors are our lifeline. The summer ... and adequate blood supply. This is a small way ...
(Date:5/19/2013)... May 19, 2013 The AMTC team will ... the Columbus Georgia Convention & Trade Center on June 1st. ... attend. AMTC auditions are free of charge. , Actors, Models ... for hundreds of successful artists and grads like Caitlin Kinney ... European Tombolini , Chris Young - on his Liquid Neon ...
(Date:5/19/2013)... Minor fender benders and serious car accidents ... to the accident to respond appropriately to the situation. ... (CDC) data from 2010, accidents, including car accidents, are ... fact, in 2005, automobile accident-related deaths cost ... 2.3 million drivers and passengers receive treatment in an ...
Breaking Medicine News(10 mins):Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Oct. ... outbreak first linked to tainted cantaloupes has risen to 25, ... 26 states, the U.S. Centers for Disease Control and Prevention ... the cantaloupes in question were recalled in mid-September, more cases ...
... as immunotherapies and targeted therapies that specifically target signaling ... in 20%-50% of cancer patients taking them, which can ... study published Oct. 18 in the Journal ... past two decades, novel antineoplastic agents have been introduced ...
... PROVIDENCE, R.I. [Brown University] A study published online Oct. ... provides some new but qualified support for the idea ... risk of developing deadly brain tumors. People with somewhat ... out the body,s immune response to allergens, were significantly less ...
... LeFevre, MD, Future of Family Medicine Professor and vice ... of Missouri, has been elected to the Institute of ... is considered one of the highest honors in the ... have demonstrated outstanding professional achievement and commitment to service. ...
... & White Healthcare in Temple is one of three sites ... doctoral psychology students that will help alleviate mental health workforce ... a five-year $638,853 grant from the Hogg Foundation for Mental ... will fund a new internship program that will enable students ...
... results from a large-scale Phase III trial of RTS,S*, published ... (NEJM), show the malaria vaccine candidate to provide young ... with an acceptable safety and tolerability profile. The results were ... & Melinda Gates Foundation in Seattle, Washington. Half the ...
Cached Medicine News:Health News:25 Deaths Now Blamed on Cantaloupe-Linked Listeria Outbreak 2Health News:Antineoplastic agents associated with thyroid dysfunction 2Health News:More evidence that allergies may help in fighting brain tumors 2Health News:Family and community medicine leader elected to Institute of Medicine 2Health News:Scott & White Healthcare is 1 of 3 in Texas to receive workforce development grants 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 3
(Date:5/17/2013)... , May 17, 2013 Sinovac Biotech Ltd. ... in China , today announced that it ... ended March 31, 2013, before market on Tuesday, May 28, ... May 28, 2013, at 8:00 a.m. EDT (May 28, 2013 ... financial results and provide an update on recent corporate developments. ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
(Date:5/16/2013)... WALTHAM, Mass. , May 16, 2013  Alere Inc. ... individuals to take charge of their health at home through ... a cash dividend of $3.00 per share on its Series ... payable on July 15, 2013 to holders of record of ... 1, 2013.  Such payment will cover the amount ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Magnetically Guided Nanoparticles May Deliver Treatments to Human,Organs -, ... and tiny iron-bearing particles to drive healthy cells to,targeted ... may lead to,a new method of delivering cells and ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080107/DC10966 ), The study team, ...
... 7 Fovea Pharmaceuticals SA, which, last,December ... financing, today announced that,its product, Recombinant human ... as Orphan Medicinal Product from the,European Commission, ... for the Evaluation of Medicinal Products (EMEA) ...
Cached Medicine Technology:Researchers Use Magnetism to Target Cells to Animal Arteries 2Researchers Use Magnetism to Target Cells to Animal Arteries 3Researchers Use Magnetism to Target Cells to Animal Arteries 4Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: